Our integrative transcriptomic analysis of H. pylori–associated gastric cancer has identified hub genes such as CXCL1, CCL20, IL12B, and TPX2 as promising biomarkers and therapeutic targets, providing valuable insights into the molecular mechanisms linking H. pylori infection to gastric carcinogenesis. The gene discussed is CCL20; the disease is gastric cancer.